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ABSTRACT
Proteins belonging to the ATP binding cassette (ABC) superfamily couple ATP
binding and hydrolysis at conserved nucleotide-binding domains (NBDs) to diverse cellular
functions. Most superfamily members are transporters, while CFTR, alone, is an ion channel.
Despite this functional difference, recent results suggest that CFTR shares a common
molecular mechanism with other members. ATP binds to partial binding sites on the surface
of the two NBDs, which then associate to form a NBD dimer, with complete, composite
catalytic sites now buried at the interface. ATP hydrolysis and -phosphate dissociation, with
loss of molecular contacts linking the two sides of the composite site, trigger dimer
dissociation. The conformational signals generated by NBD dimer formation and dissociation
are transmitted to the transmembrane domains where, in transporters, they drive the cycle of
conformational changes that translocate the substrate across the membrane; in CFTR, they
result in opening and closing (gating) of the ion-permeation pathway.
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Introduction
Cystic fibrosis is one of the most common lethal autosomal recessive disorders in
Caucasian populations, affecting approximately 60,000 people worldwide (Guggino &
Stanton 2006). The molecular basis of the disease was identified in 1989 (Riordan et al.
1989): patients had a mutation in the gene encoding the cystic fibrosis transmembrane
conductance regulator (CFTR), which resulted in abnormal electrolyte permeability in
various exocrine epithelia (Quinton 2007). The sequence clearly identified CFTR as a
member of the superfamily of ATP binding cassette (ABC) proteins (Dean & Annilo 2005;
Hollenstein et al. 2007a). Most of these are integral transmembrane proteins which harness
the chemical potential of ATP to transport very diverse compounds (referred to as allocrites)
across membranes, often against steep electrochemical potential gradients. However,
purified, reconstituted CFTR was shown to act as a channel (Bear et al. 1992), providing a
permeation pathway for anions to cross membranes, driven by their electrochemical potential
difference. Recent research suggests that the CFTR channel employs the molecular
mechanism of its transporter relatives in its own, individual way: ATPase cycles do not
power uphill allocrite transport but simply the opening and closing of the channel’s gates. In
this paper we will review the evidence supporting this view.
Structure and mechanism of ABC transporters
The minimal functional unit of ABC transporters is thought to comprise two
transmembrane domains (TMDs), that line the path across the membrane for transported
allocrites, and two nucleotide binding domains (NBDs), that bind and hydrolyse ATP
(Hollenstein et al. 2007a). In most eukaryotic transporters, as in CFTR, these 4 domains are
encoded by a single gene comprising an N-terminal TMD1 and NBD1 and a C-terminal
TMD2 and NBD2.
The numerous NBD structures solved to date reveal a conserved fold (Hung et al.
1998; Hopfner et al. 2000; Gaudet & Wiley 2001; Karpowich et al. 2001; Yuan et al. 2001;
Locher et al. 2002; Smith et al. 2002; Chen et al. 2003; Schmitt et al. 2003; Verdon et al.
2003a; Verdon et al. 2003b; Lewis et al. 2004; Thibodeau et al. 2005; Zaitseva et al. 2005;
Dawson & Locher 2006; Procko et al. 2006; Ramaen et al. 2006; Zaitseva et al. 2006;
Dawson & Locher 2007; Hollenstein et al. 2007b; Pinkett et al. 2007; Oldham et al. 2007;
Ward et al. 2007), comprising a RecA-like subdomain (“head”), and a helical subdomain,
unique to ABC transporters (“tail”). In the head subdomain, conserved motifs include the
Walker A and Walker B motifs involved in nucleotide coordination and hydrolysis, while the
conserved ABC signature sequence (LSGGQXXR) is in the tail subdomain.
NBDs can assume a dimeric “head-to-tail” arrangement. In ATP-bound crystals,
NBDs form tight dimers so that two composite ATP binding sites are formed at the interface,
each ATP molecule contacting the conserved motifs from the head of one NBD and the
signature sequence from the tail of the partner (Smith et al. 2002; Chen et al. 2003; Zaitseva
et al. 2005; Dawson & Locher 2007; Oldham et al. 2007; Ward et al. 2007). At the NBD-
NBD interface the two ATP molecules mediate a large part of the intersubunit interactions,
(acting as “molecular glue”, Karpowich et al. 2001) and indeed biochemical experiments
carried out with isolated prokaryotic NBDs confirmed the importance of the ATP molecules,
and in particular of the -phosphates, in stabilizing the dimeric conformation (Hopfner et al.
2000; Moody et al. 2002; Horn et al. 2003; Janas et al. 2003; Verdon et al. 2003a). These
observations led to the hypothesis that an ATPase cycle involving formation and dissociation
of tight NBD dimers (ATP binding → tight NBD dimerization → hydrolysis → loss of the -
phosphate → opening of the NBD-NBD interface) could drive the cyclical conformational 
changes in the TMDs resulting in uphill allocrite transport (Hopfner et al. 2000).
High resolution structures of several full length ABC transporters, including both
importers and exporters, have been solved recently (Dawson & Locher 2006; Dawson &
Locher 2007; Hollenstein et al. 2007b; Pinkett et al. 2007; Oldham et al. 2007; Ward et al.
2007). The overall architecture of the TMDs is not conserved and in some the central cavity
is accessible from the cytoplasm (inward facing) and in others from the extracellular space
(outward facing). However, in all the crystals, most of the NBD/TMD contacts are seen to
occur via a pair of structurally conserved -helices, the “coupling” helices. It has been
suggested that the conformational signal generated by the binding of ATP and NBD
dimerization could be transmitted to the TMDs via the movement of the coupling helices
closer to each other, leading to a flipping of the TMD conformation from inward-facing to
outward-facing (Hollenstein et al. 2007a).
ATP binding to CFTR’s NBDs precedes channel opening
Recent results suggest that a similar cycle of ATP binding, NBD dimerization and
ATP hydrolysis also plays an important part in controlling CFTR channel gating. In addition,
CFTR requires phosphorylation by cAMP-dependent protein kinase (PKA) (Tabcharani et al.
1991; Csanády et al. 2000; Hegedus et al. 2008). The target serines are within the regulatory
or “R” domain, which is not present in other ABC transporters. Once channels are
phosphorylated, interaction with ATP controls the channel gates (Fig. 1). The molecular
mechanism underlying the regulation of gating by ATP in pre-phosphorylated channels will
be our focus here, since its structural underpinnings are common to CFTR and transporters.
As with bacterial ABC transporters, the N-terminal NBD1 and the C-terminal NBD2
of CFTR are thought to associate, to form an intramolecular NBD1/NBD2 “heterodimer”,
with two composite binding sites formed at the interface (Kidd et al. 2004; Vergani et al.
2005; Mense et al. 2006). We will here refer to the composite site comprising NBD1 Walker
motifs and NBD2 signature as site 1, while site 2 will comprise NBD2 Walker motifs and
NBD1 signature. In CFTR, as in several other eukaryotic ABC transporters (all the other
members of the human ABCC subfamily, MRP1-9, SUR1 and SUR2, Dean et al. 2001, as
well as TAP1/TAP2, Procko et al. 2006), only interfacial site 2 presents conserved, consensus
residues in all the motifs involved in ATP binding and hydrolysis. In contrast, on both faces
of site 1 there are non-conservative substitutions at key residues. These result in the
degenerate site 1 binding tightly, but not efficiently hydrolysing the bound ATP
(Aleksandrov et al. 2001; Aleksandrov et al. 2002; Basso et al. 2003). When CFTR is reacted
with the photoactive nucleotide 8-azido ATP, labelled on the -phosphate (8-azido [ 32P]
ATP), radioactivity is retained at site 1, even after prolonged (30 minutes) incubation at 30°
C (Cui et al. 2006). If, after incubation with 8-azido [ 32P] ATP, CFTR is washed
extensively at 30° C in nucleotide-free solution before photocrosslinking, nucleotide is seen
to dissociate from site 1 with a time constant of ~ 15 min (Basso et al. 2003).
The [ATP] dependence of single-channel kinetic parameters was investigated, to
determine at which stage of the gating cycle ATP binding is required (Fig. 2). Reducing
[ATP] does not affect average open burst duration. However, at low [ATP], the closed dwell
time, the average time spent in the closed state between openings, is increased (Gunderson &
Kopito 1994; Venglarik et al. 1994; Winter et al. 1994; Zeltwanger et al. 1999; Csanády et al.
2000; Vergani et al. 2003). For wild type, a simple hyperbolic equation with an apparent
dissociation constant of ~50 M ATP describes the dose-response curve of opening rate as a
function of [ATP] (Fig. 2(b), filled circles). Thus, at sub-saturating [ATP], a binding step
appears to rate-limit channel opening, indicating that ATP binding occurs on closed channels
and is required for channel opening.
To determine whether one or both composite sites in the NBD1/NBD2 dimer are
involved in channel opening, we introduced mutations at residues belonging to the conserved
Walker motifs seen to interact directly with the bound nucleotide in solved crystal structures.
For both mutants (K464A in site 1 and D1370N in the site 2), opening rate was reduced at
low [ATP], but fast opening could be restored by increasing [ATP] (Fig. 2(b), open symbols).
These results led us to conclude that binding at either site can be made rate limiting for
channel opening, suggesting that only after ATP binds to both head subdomains the transition
to the open state becomes energetically favourable (Vergani et al. 2003). However Zhou et al
(Zhou et al. 2006), using a similar experimental strategy, obtained very different results. Sites
seen to interact with the adenine moiety of ATP were mutated. The dose-response curve of
channel opening rate as a function of [ATP] was seen to shift dramatically to the right when
the consensus site 2 was mutated (Y1219G or Y1219I) but not when the degenerate site 1
was altered (W401G). These authors conclude that ATP binding at site 2 initiates channel
opening (Chen & Hwang 2008). It is likely that the rate of opening for channels with no ATP
bound at site 1 (mono-liganded channels) can be altered by mutations at the NBD interface
around site 1. Possibly W401G channels open frequently as mono-liganded, while wild type,
with its high affinity site 1, only rarely would. More research is needed to clarify the role
played by ATP binding at site 1 in channel gating.
In any case, ATP binding – at one or both NBDs - occurs on closed channels and is
required for channel opening. In the light of recent advances in our structural understanding
of ABC transporters, this electrophysiological and biochemical evidence is consistent with
the hypothesis that after ATP binding, formation of a tight NBD1/NBD2dimer is coupled to
conformational changes in the TMDs opening the diffusion pathway for anions.
Hydrolysis at the consensus site 2 allows fast channel closure
Closing rate of wild type CFTR and mutants is not strongly affected by [ATP] (Fig.
2(c), open symbols, Gunderson & Kopito 1994; Venglarik et al. 1994; Winter et al. 1994;
Csanády et al. 2000; Vergani et al. 2003, but cfr Zeltwanger et al. 1999). However, CFTR,
like other ABC proteins, is an active ATPase (Li et al. 1996), and blocking the hydrolytic
cycle, through addition of either inorganic vanadate (Baukrowitz et al. 1994; Gunderson &
Kopito 1994) or non-hydrolysable nucleotide analogs (Gunderson & Kopito 1994; Hwang et
al. 1994), slows channel closing (Fig. 3). The effect of such compounds can be mimicked by
introducing mutations at key catalytic positions on both sides of composite site 2: in the head
of NBD2 (Carson et al. 1995; Gunderson & Kopito 1995; Ramjeesingh et al. 1999;
Zeltwanger et al. 1999; Vergani et al. 2003) and in the tail of NBD1 (Vergani et al. 2005).
Equivalent mutations at the corresponding residues in site 1 (which in CFTR has lost catalytic
activity, see above) do not significantly affect closing rate (Carson & Welsh 1995; Gunderson
& Kopito 1995; Ramjeesingh et al. 1999; Powe et al. 2002; Vergani et al. 2003), except in
particular non-hydrolytic conditions (Powe et al. 2002; Vergani et al. 2003). These
experiments suggest that hydrolysis of the nucleotide bound at site 2 triggers the rapid
channel closure seen in wild type (Fig. 1 and Fig. 3(a): fast current decay after removal of
ATP in control conditions).
Again, the evidence is consistent with the idea of NBD dimerization controlling
CFTR’s gates: fast channel closing would follow dissociation of the tight NBD dimer caused
by hydrolysis of the nucleotide bound at site 2. The equilibrium between the closed and open
conformations for the channel complex with 2 bound ATP molecules would be shifted
towards the open channel conformation, so that closing through reversal of the opening
transition (non-hydrolytic pathway) would occur rarely. For the majority of openings,
hydrolysis, triggering release of the -phosphate, and weakening of inter-NBD contacts,
would provide an alternative, rapid pathway for channel closure.
Minor changes in closing rate have been reported caused by manipulations not
expected to alter the hydrolytic rate. For example, the W401G mutant, with a weakened
contact with the adenine of the ATP molecule bound at site 1, presented a less than two-fold
reduction in mean open time, interpreted by the authors as suggesting that separation of the
NBD dimer at site 1 can constitute the rate-limiting step in channel closing (Zhou et al.
2006). It is likely that the destabilization of the NBD dimer caused by a weaker interaction
with ATP at site 1 would speed up dimer dissociation, and therefore closure, following ATP
hydrolysis at site 2.
CFTR Opening and tight NBD dimerization
Can we link the opening of the CFTR gate to the formation of an NBD1/NBD2 dimer
more directly? To do this we studied the energetic coupling between two residues on opposite
sides of the consensus site 2, before, during and after channel opening.
R555 is in the signature sequence in the NBD1 tail; T1246 is in the Walker motif in
the NBD2 head. The corresponding residues are seen to form a hydrogen bond in ATP
bound, dimeric NBD crystals (Smith et al. 2002; Chen et al. 2003; Zaitseva et al. 2005;
Zaitseva et al. 2006). In addition, multiple sequence analysis (Lockless & Ranganathan 1999)
on a sequence alignment comprising more than 10,000 NBD sequences
(http://www.sanger.ac.uk/cgi-bin/Pfam/getacc?PF00005) indicated that this pair of positions
had co-evolved. Changes in side chain at one position had been compensated by changes at
the other, so that most existing sequences contain two side chains capable of forming a
hydrogen bond which positions the two -carbons at a ~10 Å distance: either an arginine-
serine (or an equivalent arginine-threonine, as in wild type CFTR), or a lysine-asparagine pair
(see Fig. 4(b)).
To study energetic coupling we applied mutant cycle analysis (Serrano et al. 1990;
Fersht 1999). The wild type, the two single mutants (R555K and T1246N) and the double
mutant (R555K T1246N) form the corners of a thermodynamic cycle (Fig. 4(a)). If the two
residues are independent, then the effects of mutations in wild type and in mutant background
(on parallel sides of the mutant cycle) will be the same. Any non-zero difference between
mutation-linked changes on parallel sides of the cycle signifies - and can be used to quantify -
energetic coupling between the two target residues (int in Fig. 4(a); see also
Supplementary Notes to Vergani et al 2005).
We used mutation-linked changes in activation free energy for the opening reaction to
follow energetic coupling between the two target residues as the channel opens. Both single
mutations slowed channel opening, but in the double mutant fast opening was partially
restored (Fig. 4(c)). The effects on parallel sides of the mutant cycle are therefore very
different, yielding a significant energetic coupling (G‡int(opening) = –2.7±0.5 kT),
consistent with the formation of a stabilizing interaction in the transition state for the opening
reaction that was not present in the closed, ground state.
We next used open probability (Po) measurements in non-hydrolytic conditions to
infer how energetic coupling changes as the channel gates between closed and open states.
For channels containing a mutation impairing hydrolysis, the gating scheme is reduced to a
simple closed-to-open equilibrium at saturating [ATP]. In these conditions measurements of
channel Po can be used to calculate the free energy difference between the closed and open
states. Introducing the T1246N mutation in a non-hydrolytic background (mutated at a crucial
lysine, K1250R, Lerner-Marmarosh et al. 1999) strongly destabilized the open state with
respect to the closed one. However, the same T to N mutation, when introduced in the
R555K K1250R non-hydrolytic background, did not significantly alter the closed-to-open
equilibrium. The sign and magnitude of the calculated coupling energy (Gint(open-closed)
= -2.4±1.0 kT) are consistent with the two residues forming a stabilizing interaction, most
likely a hydrogen bond, in the open state that is absent in the ATP-bound closed state
(Vergani et al. 2005).
To examine coupling in the closed state preceding opening we analysed the energetics
of ATP binding. The apparent dissociation constant obtained from [ATP] dependence of
opening rate is, for CFTR (Vergani et al. 2005), a reasonable estimate for the real dissociation
constant for the ATP binding reaction at site 2. The R555K mutation did not significantly
affect apparent affinity, while the T1246N mutation reduced it to the same degree whether
the residue at position 555 was wild-type R or mutant K. The effects of the T to N mutation
in wild-type and mutant background are thus similar, yielding a negligible energetic coupling
between the two target residues (Gint(unbound-bound) = 0.3±0.5 kT). This indicates that
any coupling is similar in the closed states before and after ATP binding. Because in all
solved ATP bound structures the residue corresponding to the T1246 acceptor also acts as a
donor in a hydrogen bond to a -phosphate oxygen, it is highly unlikely that binding of ATP
would not alter the interdomain hydrogen bond involving T1246. It is more likely that there is
no significant energetic coupling between T1246 and R555 in either closed state, neither
before nor after ATP binding, with the NBD arrangement more similar to the nucleotide free
dimeric crystals (Locher et al. 2002; Chen et al. 2003; Hollenstein et al. 2007b; Pinkett et al.
2007).
In summary we have followed the interaction between two sites on opposite sides of
CFTR’s composite site 2: the target residues are not coupled in closed states that bind ATP,
but become coupled as the channel opens. The state dependence of energetic coupling we
observe, and the conservation of NBD sequences among all ABC proteins, in particular of the
residues involved in the hydrogen bond described here, provide strong experimental support
to the idea that NBD dimerization drives CFTR channel opening using the same molecular
mechanism used by its transporter relatives.
ATPase driven gating in CFTR’s TMDs
Although we do not have atomic resolution structures for CFTR’s TMDs, low
resolution structures of CFTR and of P-glycoprotein, a eukaryotic ABC exporter, revealed a
striking structural similarity (Rosenberg et al. 2004), and a CFTR homology model built on
the crystal structure of the bacterial exporter Sav1866 could be validated biochemically
(Serohijos et al. 2008). So it is likely that CFTR’s TMDs are structurally similar to those of
more conformist ABC transporters. But what subtle structural changes could turn a
transporter into a channel?
At no time point along the reaction coordinate of an active transporter can there be a
pore open to both sides of the membrane since this would allow dissipation of hard-won
electrochemical gradients (Lӓuger 1980). Thus a transporter needs to have the allocrite 
binding site, within the lipid bilayer, flanked on both sides by a gate: one gate limiting access
to/from the cytoplasm and one gate limiting access to/from the external solution. As an
example, an exporter binds the allocrite from the cytosolic side of the membrane (outer gate
closed, Fig. 5(a)(i)), then, following a conformational change, releases it to the extracellular
side (inner gate closed, Fig. 5(a)(iv)), and then in the unloaded state undergoes a further
conformational change returning to its initial outward-facing conformation (Fig. 5(a)(iv) to
Fig. 5(a)(i)).
For a protein to function as an ion channel it must provide an aqueous pore through
which the permeant ions flow. Because in this case ions move down their electrochemical
gradient, and not against it, access to the permeation pathway need not be controlled by two
gates. Since in crystals of the Sav1866 bacterial exporter, which have the NBDs in a tight
dimer conformation, the TMDs have an “outward-facing” conformation (Dawson & Locher
2006; Dawson & Locher 2007) it is simplest to imagine that CFTR’s present working gate
might be equivalent to a transporter’s external gate (Fig. 5(b)). The formation of a tight NBD
dimer would flip the TMDs into an outward facing conformation in which the structures
homologous to a transporter’s internal gate no longer prevent anion flow between the
diffusion pathway and the cytosol (Fig. 5(b)(iii) and (iv)). Hydrolysis of the ATP bound at
site 2, by triggering NBD dimer dissociation, would flip the TMDs to an inward facing
conformation in which a functional external gate acts as an effective barrier between the
external solution and the permeation pathway (Fig. 5(b)(i)).
Further observations suggest that conformational changes in CFTR’s TMDs retain
evidence of transporter ancestors. For the example exporter in Fig. 5(a), the cycle of
conformational changes must occur more frequently in the clockwise direction (central
arrow). If one could look at these TMD conformational changes in isolation, an apparent
violation of microscopic reversibility would be detected, suggesting coupling to a free energy
releasing process. For an ABC exporter this free energy is provided by the ATP hydrolysis
cycle at the NBDs. It turns out that such a violation of microscopic reversibility can be
detected by following single channel CFTR current traces. Using heavily filtered traces three
distinct conductances were observed, one closed (baseline current, C) and two open (a lower
O1 and a higher O2) conductance levels (Gunderson & Kopito 1995). Following the
interconversions between these levels, a time asymmetry was detected: the cycle C-O1-O2-C
(57%) occurred much more frequently than the reverse C-O2-O1-C (4%). The remaining
openings apparently followed linear pathways (C-O1-C, 27%, and C-O2-C, 12%), but likely
many of these included non resolved missed events. In various non-hydrolytic conditions the
O1-O2 transition virtually disappeared. Using a broader bandwidth, it was later shown that
the two open conductance levels were caused by higher (O1) or lower (O2) frequencies of a
fast flickery closure (Hennager et al. 2001). Analysis of “burst type” distribution in saturating
[ATP] revealed an apparent violation of microscopic reversibility, closely reproducing the
previous findings. In the absence of ATP, with openings occurring about 150 fold less
frequently than in saturating ATP, no time asymmetry was detected. Thus, in the presence of
ATP, the conformational states C, O1 and O2 are not at thermodynamic equilibrium, but are
kept at a steady state in which clockwise transitions (Fig. 5(b)) are more frequent than
anticlockwise ones. The simplest interpretation of these observations is that the free energy
needed to maintain the system away from equilibrium is, as in our example ABC exporter,
derived from the ATP hydrolysis cycle occurring at the NBDs.
Conclusion
The current evidence suggests that ATP hydrolysis drives CFTR channel gating. Why
would a channel use a free energy source to drive conformational changes of its gates? Is this
simply a vestigial, redundant aspect of CFTR channel function? Or could modulation of
CFTR hydrolysis provide another sensitive level of regulation for activity, as has been shown
for GTPases (Sprang et al. 2007)? Clearly we still have a long way to go before we really
understand.
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Figure 1.
CFTR gating is regulated by PKA-mediated phosphorylation and by interaction with ATP.
Current records from excised, inside-out patches, from Xenopus oocytes expressing wild type
(WT) CFTR. (a) Patch containing a small number of channels. Transitions between the
closed and the open state of individual channels can be detected. On the right, horizontal lines
show current levels reached by the indicated number of simultaneously open channels. Bars
beneath traces indicate changes in solution composition on the cytosolic side of the patch. (b)
Patch containing hundreds of WT channels. Pre-phosphorylated channels can be opened by
exposure to ATP alone. After ATP removal, all channels close within seconds.
Figure 2
Rate of channel opening is [ATP] dependent. (a) Sample WT trace. Segments with expanded
time scale are shown below. (b) Hyperbolic relationship between [ATP] and opening rates
(apparent dissociation constants are 56±5, 807±185, 391±118 M for WT, K464A and
D1370N, respectively). (c) Closing rates are [ATP] independent. Modified from Vergani et
al., 2003.
Figure 3
Blocking the hydrolytic cycle slows channel closing. (a) Because opening rate falls to
virtually zero after ATP removal, time course of current decay measures channel closing rate.
(i) Time constant for current decay in control conditions (left) is <1s, but a slow component
(slow= 21 s) appears if opening occurs in the presence of orthovanadate (VO4). In other ABC
transporters VO4 inhibits ATPase activity by acting as an analog of the pentacovalent
transition state intermediate of hydrolysis. (ii) Adenosine5’-(-imido)triphosphate
(AMPPNP) can also “lock” channels open. (b, c) Mean (±SEM, n≥15) (i) time constant (slow)
and (ii) fractional amplitude of the slow component.
Figure 4
R555 and T1246 become coupled as the channel opens. (a) Schematic representation of the
thermodynamic mutant cycle. “” beside arrows represents a mutation-linked change in any
path-independent measurement. (b) Representation of hydrogen-bonded arginine-threonine
and lysine-asparagine pairs. (c) Mutant cycle using changes in activation free energy (G‡)
for the opening reaction reveal that R555 and T1246 become energetically coupled as
channels approach the open state. For each mutation introduced (arrow) the mutation-linked
change in G‡ (mean ±sd) is indicated. Modified from Vergani et. al, 2005.
Figure 5
Conformational changes occurring in the TMDs of an exporter and in CFTR. (a) Cartoon
representing an exporter actively transporting an allocrite (large red circle), through an
alternating access and release mechanism. After a sufficient period of time the transporter
will have cycled around the 4 conformations resulting in the net transport of allocrite. The
coupled free energy releasing process is not shown. (b) Schematic representation of ATPase-
driven CFTR gating. After ATP (yellow circle) binding, formation of a tight
NBD1(green)/NBD2(blue) dimer is coupled to a conformational change in the TMDs, that
opens the (external) channel gate. Although each step is reversible, ATP hydrolysis drives
cyclic conformational changes resulting in a time asymmetry in single channel current
records (Gunderson & Kopito 1995; Hennager et al. 2001). The number of anions (small red
circles) crossing the membrane during each cycle is not stoichiometrically related to the
number of ATP molecules hydrolyzed: throughout the time the gate is open the rate of anion
flow will depend on the electrochemical potential gradient. However, on average, more than
106 Cl- ions cross the membrane during one CFTR gating cycle (i.e. >106 ions /1ATP), far
more than the 1 (or half) allocrite per ATP molecule moved by the transporter relatives.
